CID 86574704

5'-gctgttttaa-3'

Structural Information

Molecular Formula
C99H127N33O64P10
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)O)N5C=NC6=C5N=C(NC6=O)N)N7C=CC(=NC7=O)N)OP(=O)(O)OCC8C(CC(O8)N9C=NC1=C9N=C(NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)O
InChI
InChI=1S/C99H127N33O64P10/c1-39-18-124(95(142)118-85(39)134)67-10-46(189-200(154,155)172-27-58-47(11-68(181-58)125-19-40(2)86(135)119-96(125)143)190-201(156,157)174-29-60-50(14-71(183-60)128-22-43(5)89(138)122-99(128)146)192-203(160,161)176-31-62-52(15-72(186-62)130-36-110-76-80(102)106-34-108-82(76)130)195-198(150,151)169-23-54-44(133)8-65(178-54)129-35-109-75-79(101)105-33-107-81(75)129)59(182-67)28-173-202(158,159)191-48-12-69(126-20-41(3)87(136)120-97(126)144)184-61(48)30-175-206(166,167)196-53-17-74(132-38-112-78-84(132)115-93(104)117-91(78)140)187-63(53)32-177-204(162,163)193-49-13-70(127-21-42(4)88(137)121-98(127)145)180-57(49)26-171-199(152,153)188-45-9-66(123-7-6-64(100)113-94(123)141)179-56(45)25-170-205(164,165)194-51-16-73(185-55(51)24-168-197(147,148)149)131-37-111-77-83(131)114-92(103)116-90(77)139/h6-7,18-22,33-38,44-63,65-74,133H,8-17,23-32H2,1-5H3,(H,150,151)(H,152,153)(H,154,155)(H,156,157)(H,158,159)(H,160,161)(H,162,163)(H,164,165)(H,166,167)(H2,100,113,141)(H2,101,105,107)(H2,102,106,108)(H,118,134,142)(H,119,135,143)(H,120,136,144)(H,121,137,145)(H,122,138,146)(H2,147,148,149)(H3,103,114,116,139)(H3,104,115,117,140)
InChIKey
PNUOHGHAWKMLHP-UHFFFAOYSA-N
Compound name
[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl] [3-[[3-[[3-[[3-[[5-(6-aminopurin-9-yl)-3-[[5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

3111.5073 Da
Monoisotopic Mass

-19.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3112.5146 284.0
[M+Na]+ 3134.4965 288.4
[M-H]- 3110.5000 285.6
[M+NH4]+ 3129.5411 285.7
[M+K]+ 3150.4705 285.9
[M+H-H2O]+ 3094.5046 283.6
[M+HCOO]- 3156.5055 286.1
[M+CH3COO]- 3170.5212 286.7
[M+Na-2H]- 3132.4820 292.1
[M]+ 3111.5068 285.7
[M]- 3111.5078 285.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.